Clinical Trial 55393

Raleigh, NC 27612


Summary:

Explore a Clinical Research Study for People with Active Crohn’s Disease

Ozanimod (also known as RPC-1063) is an investigational medication being studied for individuals experiencing moderately to severely active Crohn’s disease. Ozanimod is an oral (taken by mouth) medication. In this clinical study, the investigational medication is taken once daily.



To qualify, you must:

  • Are 18 to 75 years of age.
  • Have been diagnosed with active Crohn’s disease (confirmed by endoscopy evidence) for at least three months.
  • Have not improved on, have lost response to, or have not been able to tolerate at least one prior Crohn’s disease medication


Qualified Participants May Receive:

To qualify, you must:

  • Study-related medication at no cost
  • Study-related medical exams at no cost
  • Compensation for time and travel


Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.